Prognostic Factors for Overall Survival in Patients with Hormone Receptor‐Positive Advanced Breast Cancer: Analyses From PALOMA‐3

BACKGROUND: This analysis investigated whether baseline characteristics affect the survival benefit derived from palbociclib‐fulvestrant and the optimal timing of cyclin‐dependent kinase 4/6 inhibitor therapy for advanced breast cancer (ABC) in patients from PALOMA‐3. PATIENTS AND METHODS: In total,...

Descripción completa

Detalles Bibliográficos
Autores principales: Rugo, Hope S., Cristofanilli, Massimo, Loibl, Sybille, Harbeck, Nadia, DeMichele, Angela, Iwata, Hiroji, Park, Yoon Hee, Brufsky, Adam, Theall, Kathy Puyana, Huang, Xin, McRoy, Lynn, Bananis, Eustratios, Turner, Nicholas C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Breast Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342589/
https://www.ncbi.nlm.nih.gov/pubmed/34037282
http://dx.doi.org/10.1002/onco.13833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342589/
https://www.ncbi.nlm.nih.gov/pubmed/34037282
http://dx.doi.org/10.1002/onco.13833

Ejemplares similares